St. Jude Gets FDA Approval for Epiducer Neurostimulation Delivery System

St. Jude Medical has received FDA clearance for its Epiducer neurostimulation lead delivery system for pain management, according to a company news release.

 

The Epiducer system allows placement of as many as three neurostimulation leads through a single entry point.

 

The system also allows introduction of St. Jude Medical S-Series paddle leads through a percutaneous entry.

 

Read the St. Jude Medical release on approval of Epiducer.

 

Related Articles on Neurostimulation Therapy:

5 Keys for Pain Management Physicians to Ensure Success in 2011

Neurostimulation System Shows Positive Findings in Treating Cluster Headache

Study: Peripheral Nerve Stimulation Reduces Migraines

 

 

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast